Skip to main content

Corbus Pharmaceuticals Holdings, Inc 8-K, filed Nov 10, 2026

Corbus Pharmaceuticals Holdings, Inc. (CRBP)

8-K 2026-11-10 For: 2026-11-10
View Original
Added on November 10, 2026

About this 8-K

Corbus Pharmaceuticals Holdings, Inc filed this 8-K on November 10, 2026.

Corbus Pharmaceuticals Holdings, Inc. reported a net loss of approximately $37.8 million for Q3 2026 and held $115.3 million in cash, cash equivalents, and investments, expected to fund operations into 2028. CRB-913 achieved 5% mean weight loss after 12 weeks. AI summary

Items reported

  • Item 2.02: Financial results
  • Item 7.01: Regulation FD disclosure
  • Item 9.01: Financial statements and exhibits